250 related articles for article (PubMed ID: 8016385)
21. Potent contractile actions of prostanoid EP3-receptor agonists on human isolated pulmonary artery.
Qian YM; Jones RL; Chan KM; Stock AI; Ho JK
Br J Pharmacol; 1994 Oct; 113(2):369-74. PubMed ID: 7834185
[TBL] [Abstract][Full Text] [Related]
22. Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins.
Walch L; de Montpreville V; Brink C; Norel X
Br J Pharmacol; 2001 Dec; 134(8):1671-8. PubMed ID: 11739243
[TBL] [Abstract][Full Text] [Related]
23. BAY u3405, a potent and selective thromboxane A2 receptor antagonist on airway smooth muscle in vitro.
McKenniff MG; Norman P; Cuthbert NJ; Gardiner PJ
Br J Pharmacol; 1991 Nov; 104(3):585-90. PubMed ID: 1839139
[TBL] [Abstract][Full Text] [Related]
24. GW627368X ((N-{2-[4-(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP4 receptor antagonist.
Wilson RJ; Giblin GM; Roomans S; Rhodes SA; Cartwright KA; Shield VJ; Brown J; Wise A; Chowdhury J; Pritchard S; Coote J; Noel LS; Kenakin T; Burns-Kurtis CL; Morrison V; Gray DW; Giles H
Br J Pharmacol; 2006 Jun; 148(3):326-39. PubMed ID: 16604093
[TBL] [Abstract][Full Text] [Related]
25. Prostaglandin E2 suppression of acetylcholine release from parasympathetic nerves innervating guinea-pig trachea by interacting with prostanoid receptors of the EP3-subtype.
Spicuzza L; Giembycz MA; Barnes PJ; Belvisi MG
Br J Pharmacol; 1998 Mar; 123(6):1246-52. PubMed ID: 9559911
[TBL] [Abstract][Full Text] [Related]
26. Prostanoid-induced relaxation of precontracted cat ciliary muscle is mediated by EP2 and DP receptors.
Chen J; Woodward DF
Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3195-201. PubMed ID: 1328113
[TBL] [Abstract][Full Text] [Related]
27. Potentiation of aggregation and inhibition of adenylate cyclase in human platelets by prostaglandin E analogues.
Matthews JS; Jones RL
Br J Pharmacol; 1993 Feb; 108(2):363-9. PubMed ID: 8448586
[TBL] [Abstract][Full Text] [Related]
28. Prostaglandin effects on the contractility of bovine trabecular meshwork and ciliary muscle.
Krauss AH; Wiederholt M; Sturm A; Woodward DF
Exp Eye Res; 1997 Mar; 64(3):447-53. PubMed ID: 9196397
[TBL] [Abstract][Full Text] [Related]
29. Evidence for thromboxane receptor mediated contraction of guinea-pig and human airways in vitro by prostaglandin (PG) D2, 9 alpha,11 beta-PGF2 and PGF2 alpha.
Featherstone RL; Robinson C; Holgate ST; Church MK
Naunyn Schmiedebergs Arch Pharmacol; 1990 May; 341(5):439-43. PubMed ID: 2142256
[TBL] [Abstract][Full Text] [Related]
30. Prostaglandin E2 inhibits mast cell-dependent bronchoconstriction in human small airways through the E prostanoid subtype 2 receptor.
Säfholm J; Manson ML; Bood J; Delin I; Orre AC; Bergman P; Al-Ameri M; Dahlén SE; Adner M
J Allergy Clin Immunol; 2015 Nov; 136(5):1232-9.e1. PubMed ID: 25962903
[TBL] [Abstract][Full Text] [Related]
31. Contractile effects of prostanoids on fetal rabbit ductus arteriosus.
Smith GC; McGrath JC
J Cardiovasc Pharmacol; 1995 Jan; 25(1):113-8. PubMed ID: 7723339
[TBL] [Abstract][Full Text] [Related]
32. Characterization of a prostanoid EP3-receptor in guinea-pig aorta: partial agonist action of the non-prostanoid ONO-AP-324.
Jones RL; Qian YM; Chan KM; Yim AP
Br J Pharmacol; 1998 Nov; 125(6):1288-96. PubMed ID: 9863659
[TBL] [Abstract][Full Text] [Related]
33. In vitro characterization of prostanoid receptors on human myometrium at term pregnancy.
Senior J; Marshall K; Sangha R; Clayton JK
Br J Pharmacol; 1993 Feb; 108(2):501-6. PubMed ID: 8448599
[TBL] [Abstract][Full Text] [Related]
34. Individual variations of prostanoid agonist responses in rabbit aorta: evidence for the independent regulation of prostanoid receptor subtypes.
Keith RA; Salama AI
Br J Pharmacol; 1987 Sep; 92(1):133-48. PubMed ID: 3664085
[TBL] [Abstract][Full Text] [Related]
35. Interaction of BW A868C, a prostanoid DP-receptor antagonist, with two receptor subtypes in the rabbit isolated saphenous vein.
Lydford SJ; McKechnie KC; Leff P
Prostaglandins; 1996 Aug; 52(2):125-39. PubMed ID: 8880898
[TBL] [Abstract][Full Text] [Related]
36. Distinction between relaxations induced via prostanoid EP(4) and IP(1) receptors in pig and rabbit blood vessels.
Jones RL; Chan K
Br J Pharmacol; 2001 Sep; 134(2):313-24. PubMed ID: 11564649
[TBL] [Abstract][Full Text] [Related]
37. 8-Epi-PGF2 alpha, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro.
Kawikova I; Barnes PJ; Takahashi T; Tadjkarimi S; Yacoub MH; Belvisi MG
Am J Respir Crit Care Med; 1996 Feb; 153(2):590-6. PubMed ID: 8564103
[TBL] [Abstract][Full Text] [Related]
38. Characterization of excitatory prostanoid receptors in the human umbilical artery in vitro.
Boersma JI; Janzen KM; Oliveira L; Crankshaw DJ
Br J Pharmacol; 1999 Dec; 128(7):1505-12. PubMed ID: 10602330
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological evidence for thromboxane receptor heterogeneity--implications for the eye.
Krauss AH; Woodward DF; Burk RM; Gac TS; Gibson LL; Protzman CE; Abbass F; Marshall K; Senior J
J Ocul Pharmacol Ther; 1997 Aug; 13(4):303-12. PubMed ID: 9261766
[TBL] [Abstract][Full Text] [Related]
40. EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries.
Davis RJ; Murdoch CE; Ali M; Purbrick S; Ravid R; Baxter GS; Tilford N; Sheldrick RL; Clark KL; Coleman RA
Br J Pharmacol; 2004 Feb; 141(4):580-5. PubMed ID: 14744815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
